Search results
Bright Light, Sharper Mind: Lighting Affects Cognition - Neuroscience News
Neuroscience News· 32 minutes agoThe study utilized advanced 7 Tesla fMRI to show that higher levels of light improve cognitive...
Mastering the Mind: Brain Wave Beta Bursts and Their Role in Cognitive Control
SciTechDaily· 5 hours agoStudying these bursts would improve understanding of cognition and clinical disorders, researchers...
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic...
Morningstar· 1 day agoCognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders ...
Can supplements really help prevent dementia?
The Telegraph via Yahoo News· 4 hours agoBy 2025, it’s estimated that over one million people in the UK will have a diagnosis of dementia. It’s a sobering thought, but new research suggests that...
An Epitaph for Daniel Dennett, Philosopher of Consciousness
Scientific American· 6 hours agoPhilosopher Daniel Dennett died a few days ago, on April 19. Dennett’s death feels like the end of...
Brain Rhythms Are Key to Understanding Cognition - Neuroscience News
Neuroscience News· 6 days agoSummary: A new study emphasizes the importance of brain rhythms in understanding cognition. The...
Conscious, sentient thought likely for many or most animals: scientists
Houston Today· 2 hours agoThe New York Declaration on Animal Consciousness, released Friday, was signed by 39 cognition scholars at universities from Canada to Australia. It says there is “at least ...
The Trump Trial Is Already Influencing Public Opinion in Big Ways
Slate· 4 days agoFour days in, and with the jury just selected, those in the commentariat class are already ready to...
Cognition Therapeutics (NASDAQ:CGTX) and Black Diamond Therapeutics (NASDAQ:BDTX) Head to Head...
ETF DAILY NEWS· 7 days agoCognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) are both small-cap medical companies, but which is the ...
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial
FOX 59 Indianapolis· 1 day agoActinogen Medical Limited (ASX: ACW) announces the full enrolment of 167 participants in the Company's XanaCIDD phase 2a clinical trial in patients with cognitive impairment in major depressive ...